Stocks and Investing Stocks and Investing
Fri, October 11, 2013
Thu, October 10, 2013
Wed, October 9, 2013
Tue, October 8, 2013
Mon, October 7, 2013
Fri, October 4, 2013
Thu, October 3, 2013
Wed, October 2, 2013
Tue, October 1, 2013
Mon, September 30, 2013
Fri, September 27, 2013
Thu, September 26, 2013
Wed, September 25, 2013
Tue, September 24, 2013
Mon, September 23, 2013
Fri, September 20, 2013
Thu, September 19, 2013
Wed, September 18, 2013
Tue, September 17, 2013
Mon, September 16, 2013
Fri, September 13, 2013
Thu, September 12, 2013
Wed, September 11, 2013
Tue, September 10, 2013
Mon, September 9, 2013
Fri, September 6, 2013
Thu, September 5, 2013
Wed, September 4, 2013
Tue, September 3, 2013
Fri, August 30, 2013
Wed, August 28, 2013
Tue, August 27, 2013
Mon, August 26, 2013

Christopher Raymond Upgraded (AMGN) to Buy and Increased Target to $140 on, Aug 26th, 2013


Published on 2024-10-25 03:12:29 - WOPRAI, Christopher Raymond
  Print publication without navigation


Christopher Raymond of Piper Sandler, Upgraded "Amgen Inc." (AMGN) to Buy and Increased Target from $120 to $140 on, Aug 26th, 2013.

Christopher has made no other calls on AMGN in the last 4 months.



There is 1 other peer that has a rating on AMGN. Out of the 1 peers that are also analyzing AMGN, 0 agree with Christopher's Rating of Hold.



This is the rating of the analyst that currently disagrees with Christopher


  • Salveen Richter of "Goldman Sachs" Upgraded from Hold to Strong Buy and Increased Target to $130 on, Wednesday, May 1st, 2013